Drug Chatter -- Tracking biopharma stock chatter

Profile for Acorda Therapeutics, Inc. (ACOR)

« Back to company index

ACOR Chatter Timeline

Stock Ticker for ACOR

Most Active Tweeters for ACOR

UserTweets
@TickerReport 6
@RoboSchmobo 4
@CFinancialNews 3
@SleekMoneycom 3
@stocknewstimes 3

Recent Tweets for ACOR

storminvestor @storminvestor
Acorda Therapeutics, Inc. $ACOR Given Consensus Rating of “Hold” by Analysts https://t.co/5uC4OeKpdd
September 24th 2017, 11:09pm
SleekMoneycom @SleekMoneycom
Somewhat Positive Press Coverage Somewhat Unlikely to Affect Acorda Therapeutics $ACOR Stock Price https://t.co/pWh6aoKAtX
September 24th 2017, 7:09pm
WatchlistN @WatchlistN
Acorda Therapeutics $ACOR Earning Somewhat Positive Press Coverage, Study Finds https://t.co/yJC4pX5Pw7
September 23rd 2017, 8:09pm
chaffeybreeze @chaffeybreeze
Prudential Financial Inc. Reduces Stake in Acorda Therapeutics, Inc. $ACOR https://t.co/Iv5KTI4LtL
September 23rd 2017, 5:09am
IRAMarketReport @IRAMarketReport
Prudential Financial Inc. Reduces Stake in Acorda Therapeutics, Inc. $ACOR https://t.co/AUTPz2Ckyf
September 23rd 2017, 5:09am
TickerReport @TickerReport
Brokerages Set Acorda Therapeutics, Inc. $ACOR Price Target at $24.29 https://t.co/qCFh5RB1Fl
September 22nd 2017, 3:09pm
TickerReport @TickerReport
Brokerages Set Acorda Therapeutics, Inc. $ACOR Price Target at $24.29 https://t.co/Jxl9I4siNB
September 22nd 2017, 3:09pm
emq_news @emq_news
Brokerages Set Acorda Therapeutics, Inc. $ACOR Price Target at $24.29 https://t.co/EzfiVhEdR1
September 22nd 2017, 3:09pm
dakotafinancial @dakotafinancial
Zacks: Brokerages Expect Acorda Therapeutics, Inc. $ACOR Will Announce Quarterly Sales of $151.15 Million https://t.co/mUdLz2AjRI
September 22nd 2017, 3:09pm
SleekMoneycom @SleekMoneycom
Brokerages Set Acorda Therapeutics, Inc. $ACOR Target Price at $24.29 https://t.co/CMBUQuNeYY
September 20th 2017, 5:09pm
TranscriptDaily @TranscriptDaily
Brokerages Set Acorda Therapeutics, Inc. $ACOR Target Price at $24.29 https://t.co/cWrrdHX0rZ
September 20th 2017, 5:09pm
CFinancialNews @CFinancialNews
$151.15 Million in Sales Expected for Acorda Therapeutics, Inc. $ACOR This Quarter https://t.co/RfmLN24Lig
September 19th 2017, 6:09am
intercooleronli @intercooleronli
$151.15 Million in Sales Expected for Acorda Therapeutics, Inc. $ACOR This Quarter https://t.co/LQU7ymnG2B
September 19th 2017, 6:09am
Regencells @Regencells
RT @cmiller1225: Acorda sinks after FDA refuses Inbrija NDA https://t.co/XtLo5YsqtO $ACOR #NDA https://t.co/GkWOU3MjIU
September 18th 2017, 11:09am
cmiller1225 @cmiller1225
Acorda sinks after FDA refuses Inbrija NDA https://t.co/XtLo5YsqtO $ACOR #NDA https://t.co/GkWOU3MjIU
September 18th 2017, 11:09am
emq_news @emq_news
Acorda Therapeutics, Inc. $ACOR Shares Sold by Comerica Bank https://t.co/sB01AQgLtR
September 18th 2017, 5:09am
TickerReport @TickerReport
Acorda Therapeutics, Inc. $ACOR Shares Sold by Comerica Bank https://t.co/FTUB9kmqwE
September 18th 2017, 5:09am
TickerReport @TickerReport
Acorda Therapeutics, Inc. $ACOR Shares Sold by Comerica Bank https://t.co/sSFjCFwf0C
September 18th 2017, 5:09am
SPNewsAnalysis @SPNewsAnalysis
Acorda Therapeutics $ACOR Given Daily News Sentiment Score of 0.20 https://t.co/6JyNJZ9AZh
September 17th 2017, 7:09pm
stocknewstimes @stocknewstimes
Acorda Therapeutics $ACOR Given Daily News Sentiment Score of 0.20 https://t.co/VJ8b1RdQ5E
September 17th 2017, 7:09pm
SleekMoneycom @SleekMoneycom
Acorda Therapeutics $ACOR Given Daily News Sentiment Score of 0.20 https://t.co/pWh6aoKAtX
September 17th 2017, 7:09pm
storminvestor @storminvestor
Acorda Therapeutics $ACOR Given Daily News Sentiment Score of 0.20 https://t.co/Sy5ZpTd4af
September 17th 2017, 7:09pm
chaffeybreeze @chaffeybreeze
Acorda Therapeutics Inc $ACOR Given Average Rating of “Hold” by Analysts https://t.co/a92lqy4CWt
September 17th 2017, 4:09pm
intercooleronli @intercooleronli
Acorda Therapeutics Inc $ACOR Given Average Rating of “Hold” by Analysts https://t.co/EFuSKLl2pG
September 17th 2017, 4:09pm
IRAMarketReport @IRAMarketReport
Acorda Therapeutics Inc $ACOR Given Average Rating of “Hold” by Analysts https://t.co/7yiFJtjfzj
September 17th 2017, 4:09pm
CFinancialNews @CFinancialNews
Acorda Therapeutics Inc $ACOR Given Average Rating of “Hold” by Analysts https://t.co/xXou3gJwx3
September 17th 2017, 4:09pm
RoboSchmobo @RoboSchmobo
RT @HealthierIT: Acorda sinks after FDA refuses Inbrija NDA https://t.co/poDIoLhhvi $ACOR #NDA https://t.co/97CIhV0R5m
September 17th 2017, 10:09am
HealthierIT @HealthierIT
Acorda sinks after FDA refuses Inbrija NDA https://t.co/poDIoLhhvi $ACOR #NDA https://t.co/97CIhV0R5m
September 17th 2017, 10:09am
noritsunagirota @noritsunagirota
Acorda Therapeutics $ACOR Stock Price Declined While Armistice Capital Decreased Position by $2.16 Million ...
September 17th 2017, 10:09am
TickerReport @TickerReport
SG Americas Securities LLC Grows Holdings in Acorda Therapeutics, Inc. $ACOR https://t.co/cpFtM9kYzg
September 17th 2017, 4:09am
emq_news @emq_news
SG Americas Securities LLC Grows Holdings in Acorda Therapeutics, Inc. $ACOR https://t.co/1NQb9j3JeO
September 17th 2017, 4:09am
TickerReport @TickerReport
SG Americas Securities LLC Grows Holdings in Acorda Therapeutics, Inc. $ACOR https://t.co/JtHLY7Te0T
September 17th 2017, 4:09am
FancyFinancy @FancyFinancy
RT @HealthyCarnivor: Acorda sinks after FDA refuses Inbrija NDA https://t.co/DKlXTsQGLs $ACOR #NDA https://t.co/pbWpSwnUi0
September 16th 2017, 8:09pm
HealthyCarnivor @HealthyCarnivor
Acorda sinks after FDA refuses Inbrija NDA https://t.co/DKlXTsQGLs $ACOR #NDA https://t.co/pbWpSwnUi0
September 16th 2017, 8:09pm
bnbdailynews @bnbdailynews
Acorda Therapeutics, Inc. $ACOR Receives Buy Rating from Stifel Nicolaus https://t.co/n3tXz7v4BF
September 16th 2017, 5:09am
bnbdailynews @bnbdailynews
Acorda Therapeutics, Inc. $ACOR Receives “Hold” Rating from Cantor Fitzgerald https://t.co/adCZbEnP0I
September 16th 2017, 12:09am
stocknewstimes @stocknewstimes
Zacks: Brokerages Expect Acorda Therapeutics, Inc. $ACOR Will Post Quarterly Sales of $151.15 Million https://t.co/pECSA6jUyu
September 15th 2017, 11:09pm
Regencells @Regencells
Acorda sinks after FDA refuses Inbrija NDA https://t.co/bXWpIRATXv $ACOR #NDA https://t.co/5P5IMZlH3D
September 15th 2017, 10:09pm
OneMedWorld @OneMedWorld
Acorda sinks after FDA refuses Inbrija NDA https://t.co/LqUS9xWno9 $ACOR #NDA https://t.co/fKdseFivSD
September 15th 2017, 12:09pm
RoboSchmobo @RoboSchmobo
RT @UCCharting: Acorda sinks after FDA refuses Inbrija NDA https://t.co/FTCRCbzktA $ACOR #NDA https://t.co/ocl9ajDqY7
September 15th 2017, 9:09am
UCCharting @UCCharting
Acorda sinks after FDA refuses Inbrija NDA https://t.co/FTCRCbzktA $ACOR #NDA https://t.co/ocl9ajDqY7
September 15th 2017, 9:09am
cmiller1225 @cmiller1225
Acorda sinks after FDA refuses Inbrija NDA $ACOR #NDA https://t.co/UeJznnl4X8 https://t.co/OOIq9OPOB8
September 15th 2017, 12:09am
stocknewstimes @stocknewstimes
Comparing Acorda Therapeutics $ACOR and Ritter Pharmaceuticals $RTTR https://t.co/ERElHMefKt
September 14th 2017, 11:09pm
WeekHerald @WeekHerald
Cantor Fitzgerald Reaffirms Hold Rating for Acorda Therapeutics, Inc. $ACOR https://t.co/N3LJdbyhdm
September 14th 2017, 6:09am
intercooleronli @intercooleronli
Research Analysts’ Recent Ratings Updates for Acorda Therapeutics $ACOR https://t.co/nRc3c4pM7A
September 14th 2017, 5:09am
WKRBNews @WKRBNews
Research Analysts’ Recent Ratings Updates for Acorda Therapeutics $ACOR https://t.co/z8qatVlqq0
September 14th 2017, 5:09am
dailypoliticaln @dailypoliticaln
Research Analysts’ Recent Ratings Updates for Acorda Therapeutics $ACOR https://t.co/q2XgcWFcda
September 14th 2017, 5:09am
dailymailtimes @dailymailtimes
Research Analysts’ Recent Ratings Updates for Acorda Therapeutics $ACOR https://t.co/NOVSuQv3hb
September 14th 2017, 5:09am
midetimes @midetimes
Research Analysts’ Recent Ratings Updates for Acorda Therapeutics $ACOR https://t.co/QaHDm2FYL7
September 14th 2017, 5:09am
CFinancialNews @CFinancialNews
Research Analysts’ Recent Ratings Updates for Acorda Therapeutics $ACOR https://t.co/B8BgDMBlCQ
September 14th 2017, 5:09am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.